SEC Obtains Final Judgments as to CBD-Inhaler Company, Its CEO Charged With Making Fraudulent Statements
December 13, 2025
December 13, 2025
WASHINGTON, Dec. 13 -- The Securities and Exchange Commission issued the following litigation release (No. 3:23-cv-2081-S; N.D. Tex. filed Sept. 18, 2023):
* * *
Securities and Exchange Commission v. Rapid Therapeutic Science Laboratories, Inc. and Donal R. Schmidt, Jr., No. 3:23-cv-2081-S (N.D. Tex. filed Sept. 18, 2023)
On November 24, 2025, the U.S. District Court for the Northern District of Texas entered final judgments as to Dallas-based Rapid Therape . . .
* * *
Securities and Exchange Commission v. Rapid Therapeutic Science Laboratories, Inc. and Donal R. Schmidt, Jr., No. 3:23-cv-2081-S (N.D. Tex. filed Sept. 18, 2023)
On November 24, 2025, the U.S. District Court for the Northern District of Texas entered final judgments as to Dallas-based Rapid Therape . . .